MHRA's approval of the Pfizer/BioNTech vaccine explained
By DTA | 10th December 2020 | News
MHRA Chief Executive Dr June Raine explains the process behind the Agency's approval of the Pfizer/BioNTech vaccine:
"The year 2020 has been a difficult one for us all. As COVID-19 has affected almost every aspect of our lives, it has at times been hard to foresee an end. But last week, we reached an important milestone in our fight against the disease. On Wednesday, my Agency the MHRA announced the authorisation of the Pfizer/BioNTech COVID-19 vaccine for supply here, making the UK the first country in the Western hemisphere to issue an approval.
Before some 30 years at the MHRA and its predecessor, working on keeping medicines safe for the public, I was a general practitioner for 5 years. Patient safety has always been at the heart of my work. It has been no different for this vaccine, nor will it be for the others to come.
People rightly ask me how we achieved this outcome before others... " read the full news story here